Evaluation of appetite efficacy of plant product

Evaluation of appetite efficacy of Gentiana olivieri in children with loss of appetite

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT2013091114630N1

Enrollment

Registered

2013-10-15

Start date

2013-09-23

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Loss of appetite. Anorexia

Interventions

intervention : 2.5 mg/kg twice daily-15 days control: 2.5 mg/kg twice daily-15 days.

Placebo

intervention : 2.5 mg/kg twice daily-15 days control: 2.5 mg/kg twice daily-15 days

Eligibility

Sex/Gender

All

Age

3 Years to 7 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: children of 3-7 years old coming to tuba clinic whose appetite is low; they should have negative urine and stool infection and parasite tests; they don't have chronic disease; A written consent will be taken before the children are recruited to the study. Exclusion criteria: children whose urine and feces tests are positive regarding urinary infections and feces parasites; Children with gastrointestinal and liver diseases, mental retardation, celiac;... : children who consume nutritional supplements or medications which affect food intake and appetite.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Appetite. Timepoint: Daily. Method of measurement: Calorie intake.	—

Secondary

Measure	Time frame
Hungry. Timepoint: daily. Method of measurement: VAS curve.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactElham Nayebi

Mazandaran University Of Medical Sciences

Elham7773@yahoo.com+98 21 2251 7174

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026